BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 47 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $224,000 | -1.3% | 200,000 | 0.0% | 0.00% | – |
Q1 2019 | $227,000 | +1.8% | 200,000 | 0.0% | 0.00% | – |
Q4 2018 | $223,000 | -7.1% | 200,000 | 0.0% | 0.00% | – |
Q3 2018 | $240,000 | +1.3% | 200,000 | 0.0% | 0.00% | – |
Q2 2018 | $237,000 | +7.7% | 200,000 | 0.0% | 0.00% | – |
Q1 2018 | $220,000 | -7.2% | 200,000 | 0.0% | 0.00% | – |
Q4 2017 | $237,000 | -87.2% | 200,000 | -87.1% | 0.00% | -100.0% |
Q3 2017 | $1,849,000 | -22.6% | 1,545,000 | -23.1% | 0.00% | 0.0% |
Q2 2017 | $2,390,000 | +6.6% | 2,009,000 | +5.7% | 0.00% | 0.0% |
Q1 2017 | $2,243,000 | -45.3% | 1,900,000 | -45.7% | 0.00% | -50.0% |
Q4 2016 | $4,103,000 | +143.8% | 3,500,000 | +159.3% | 0.00% | +100.0% |
Q3 2016 | $1,683,000 | -9.0% | 1,350,000 | +7844.0% | 0.00% | 0.0% |
Q2 2016 | $1,850,000 | -67.0% | 16,994 | -99.6% | 0.00% | -71.4% |
Q3 2015 | $5,601,000 | +603.6% | 4,168,000 | +733.6% | 0.01% | +600.0% |
Q2 2015 | $796,000 | -81.8% | 500,000 | -82.7% | 0.00% | -75.0% |
Q1 2015 | $4,369,000 | -55.9% | 2,885,000 | -64.3% | 0.00% | -55.6% |
Q4 2014 | $9,903,000 | +10.8% | 8,080,000 | -1.0% | 0.01% | +28.6% |
Q3 2014 | $8,941,000 | +4.0% | 8,165,000 | 0.0% | 0.01% | 0.0% |
Q2 2014 | $8,599,000 | +29.4% | 8,165,000 | +36.4% | 0.01% | 0.0% |
Q1 2014 | $6,643,000 | +21.9% | 5,985,000 | +17.5% | 0.01% | +40.0% |
Q4 2013 | $5,449,000 | – | 5,095,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCHRODER INVESTMENT MANAGEMENT GROUP | 12,400,000 | $1,326,025,000,000 | 1.66% |
GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $8,643,000 | 0.79% |
OAKTREE CAPITAL MANAGEMENT LP | 37,500,000 | $40,523,000 | 0.74% |
ADVENT CAPITAL MANAGEMENT /DE/ | 46,800,000 | $50,350,000 | 0.63% |
Jabre Capital Partners S.A. | 6,500,000 | $7,035,000 | 0.54% |
Nicholas Investment Partners, LP | 6,470,000 | $6,919,000 | 0.53% |
Polar Asset Management Partners Inc. | 10,000,000 | $10,788,000 | 0.46% |
AVIVA PLC | 50,700,000 | $54,594,000 | 0.46% |
Man Investments (CH) AG | 1,000,000 | $1,082,000 | 0.44% |
RWC Asset Management LLP | 3,500,000 | $3,769,000 | 0.40% |